Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × Melphalan × Clear all

Status

Completed 12 Withdrawn 3 Not yet recruiting 2 Unknown 1 No longer available 1 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 22 Lymphoma 16 Neoplasms, Plasma Cell 12 Lymphoma, Non-Hodgkin 11 Lymphoma, Large B-Cell, Diffuse 8 Neuroblastoma 7 Lymphoma, Mantle-Cell 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Hodgkin Disease 6 Myelodysplastic Syndromes 5 Lymphoma, Large-Cell, Immunoblastic 5 Leukemia 5 Burkitt Lymphoma 5 Lymphoma, Follicular 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Recurrence 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Acute 3 Sarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroectodermal Tumors, Primitive 2 Medulloblastoma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Biphenotypic, Acute 2 Dendritic Cell Sarcoma, Interdigitating 2 Brain Neoplasms 2

Interventions

Nivolumab 22 pembrolizumab 20 Ipilimumab 13 toripalimab 11 Temozolomide 11 Biopsy 8 Dacarbazine 7 Blood Specimen Collection 7 Cyclophosphamide 6 trametinib 5 fludarabine 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 durvalumab 4 binimetinib 4 aldesleukin 4 Interleukin-2 4 Injections 4 tislelizumab 3 palbociclib 3 encorafenib 3 apatinib 3 Sorafenib 3 Introns 3 Cisplatin 3 Carboplatin 3 Canvaxin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01920516 2019-02-27

ILI

International Group of Endovascular Oncology

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡